Loading...
ICON Public Limited Company
ICLR•NASDAQ
Healthcare
Medical - Diagnostics & Research
$187.01
$-8.00(-4.10%)
ICON Public Limited Company (ICLR) Financial Performance & Income Statement Overview
Review ICON Public Limited Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1.99%
↑ 1.99%
Operating Income Growth
14.82%
↑ 14.82%
Net Income Growth
29.26%
↑ 29.26%
Operating Cash Flow Growth
10.82%
↑ 10.82%
Operating Margin
13.11%
↑ 13.11%
Gross Margin
27.36%
↑ 27.36%
Net Profit Margin
9.82%
↑ 9.82%
ROE
8.28%
↑ 8.28%
ROIC
7.55%
↑ 7.55%
ICON Public Limited Company (ICLR) Income Statement & Financial Overview
Review ICON Public Limited Company's (ICLR) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $2.02B | $2.001B | $2.04B | $2.03B |
| Cost of Revenue | $1.55B | $1.44B | $1.44B | $1.44B |
| Gross Profit | $463.88M | $558.65M | $599.37M | $591.41M |
| Gross Profit Ratio | $0.23 | $0.28 | $0.29 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $205.006M | $198.38M | $151.44M | $205.09M |
| Operating Expenses | $205.006M | $339.09M | $302.34M | $305.98M |
| Total Costs & Expenses | $1.76B | $1.78B | $1.74B | $1.74B |
| Interest Income | $2.05M | $1.80M | $3.008M | $2.43M |
| Interest Expense | $50.15M | $47.61M | $51.43M | $53.30M |
| Depreciation & Amortization | $97.72M | $95.96M | $96.66M | $93.03M |
| EBITDA | $308.98M | $317.32M | $365.65M | $380.90M |
| EBITDA Ratio | $0.15 | $0.16 | $0.18 | $0.19 |
| Operating Income | $258.88M | $219.56M | $297.02M | $285.43M |
| Operating Income Ratio | $0.13 | $0.11 | $0.15 | $0.14 |
| Other Income/Expenses (Net) | -$97.76M | -$45.81M | -$48.42M | -$50.87M |
| Income Before Tax | $161.11M | $173.75M | $248.60M | $234.56M |
| Income Before Tax Ratio | $0.08 | $0.09 | $0.12 | $0.12 |
| Income Tax Expense | -$21.86M | $19.60M | -$11.39M | $37.44M |
| Net Income | $182.97M | $154.15M | $260.00M | $197.13M |
| Net Income Ratio | $0.09 | $0.08 | $0.13 | $0.10 |
| EPS | $2.31 | $1.89 | $3.18 | $2.38 |
| Diluted EPS | $2.30 | $1.87 | $3.16 | $2.36 |
| Weighted Avg Shares Outstanding | $79.25M | $81.79M | $81.79M | $82.83M |
| Weighted Avg Shares Outstanding (Diluted) | $79.55M | $82.24M | $82.24M | $83.45M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan